Research On The Developing Strategy Of NCPC

The development of strategic management is an important component part of strategic management. North China Pharmaceutical Group as the large pharmaceutical companies, along with international and domestic environment of change, facing the living environment more complex than ever, in order to seek survival in the competition and development, development of practical development strategy has become particularly important.This article first chapter of that thesis research background, purpose and meaning, and study the ideas and methods. Chapter II of the Strategic Review of the theory do. Chapter III of the North China Pharmaceutical Group Corporation external environmental factors were analyzed, mainly related to PEST (Political, Economic, Society, Technology) analysis, environmental analysis of the pharmaceutical industry to identify the opportunities and threats. Chapter 4 of the North China Pharmaceutical Company internal resources, an analysis of the major companies involved in the management, marketing, finance, production, research, development and other aspects of the key strengths and weaknesses. Chapter V of the corporate culture were discussed, the analysis of the cultural system of the old system under the disadvantages of the North China Pharmaceutical Group under the new culture of corporate culture of enterprise development strategies. Chapter VI to the company's development goals, a strategic choice and implementation, using SWOT Analysis of how to play the opportunity to profit from the advantages (SO), namely the North China Pharmaceutical Group should be used to support the national pharmaceutical industry policy, by virtue of antibiotics Group The areas of brand recognition, bigger and stronger. With the scale of production costs to maintain a leading edge. Relocation and a new round of the District building opportunities and seek to establish new strategic alliance. Analysis of how to make use of advantages and avoid the threat (ST) is the North China Pharmaceutical Group should be the development of new market segments. Acceleration technology research and development, to differentiate their products. Analysis of how to overcome weaknesses, opportunities to benefit from the (WO), that should change in North China Pharmaceutical Group Corporation system, establish a highly efficient distribution network model. Establish a more scientific product portfolio. Reasonable performance evaluation and to stimulate the enthusiasm of the staff. WT strategy, At this point in the internal capacity of disadvantaged businesses and environmental threats, enterprises should adopt austerity-type strategy, reduce or change the investment strategy products.Kingston Advisory Group through the four-way grid, that the North China Pharmaceutical Group of chemical and pharmaceutical raw materials preparation plate to plate "cash cow" products, should remain in the market, and consolidate and maintain its market-leading position biopharmaceutical plate "Star" products, should increase input in the market to maintain market growth and repulse the attack competitors; nutritional health products and biological-chemical plate for the "problem" products, but the nutritional health products plate in some products Soy isoflavones, lycopene and VC real commitment to a "cash cow" role, should increase market access in order to increase its market share to make sure that they become a "star." Products in the "skinny dog" products for the production and sales in recent years have been slow glass products and packaging materials should stop production. North China Pharmaceutical Group Corporation should strengthen strategic management, strategic planning to develop a clear direction, based on a company's strategic plan to adjust and optimize the company's organizational structure, strengthen the management team building.